The Latest Breaking News on Pharma

The medical industry is poised for growth this year, driven by expanding medical needs and increasing federal support. Moreover, the industry is expected to thrive in times of uncertainty due to steady demand. Thus, quality medical stocks McKesson Corp. (MCK) and Cardinal Health (CAH) could be ideal buys this year.…

WASHINGTON — Factions of the health care system and members of Congress are turning their fire on an oft-maligned part of the drug pricing system — the middlemen who negotiate discounts with drug companies on behalf of health plans.

Emily O'Reilly, who heads the EU Ombudsman, says she has been stonewalled by the European Commission when asking for information in relation to the "Pfizergate" affair. At the core of this controversy is an exchange of text messages between the EU Commission chief and the CEO of Pfizer in the…

Novavax plans to update its Covid vaccine for new variants, and NVAX stock outperformed its vaccine stock rivals.

Pfizer (PFE) topped Wall Street’s EPS and revenue estimates in the third quarter. Moreover, the company updated its guidance for fiscal 2022. Analysts expect the stock to rise more than 16% in the near term. Therefore, it could be wise to buy the stock now. Keep reading….

Many Sudanese activists are becoming concerned about the spread of the highly addictive synthetic drug methamphetamine, nicknamed “ice” or “Satan”. In light of the growing issue, some have started campaigns to raise awareness and opened rehabilitation centres. They say the government is failing to do enough.

The first significant stage of post-Roe abortion litigation is underway and focuses heavily on abortion pills. GenBioPro, a pharmaceutical company that makes the drug mifepristone, has asked a federal court to declare that West Virginia’s anti-abortion law is inconsistent with the Federal Drug Administration’s determination that the pill is safe…

Hong Kong will ban CBD starting Wednesday, labeling it a “dangerous drug.”

The Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements

Over 4,000 workers could see their pay reduced due to shift changes

Nitrous oxide is one of the most commonly-used drugs among 16 to 24-year-olds in England and can have damaging side-effects, the Home Office said.